Growth Hormone Deficiency
📧 Sign up to get email alerts when something new happens for Growth Hormone Deficiency.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-06-02Clinical Trial Update: Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain Injury [Phase 4]
Pfizer's Phase 4 trial evaluating growth hormone treatment for adults with growth hormone deficiency after traumatic brain injury was termin…
-
FDA approval · 2010-04-12FDA Approved: ZOMACTON — Supplemental Application (Ferring Pharmaceuticals Inc.)
FDA approved a supplemental application for ZOMACTON (somatropin) from Ferring Pharmaceuticals Inc. The action represents an additional regu…
-
CLINICAL_TRIALS research · 2010-03-17Clinical Trial Update: Treatment of Children With Insufficient Secretion of Growth Hormone [Phase 3]
This Phase 3 trial sponsored by LG Life Sciences aims to treat children with growth hormone deficiency, but the current status is unknown.
-
CLINICAL_TRIALS trial_result · 2010-03-05Clinical Trial Update: Sexually Dimorphic Effects of GHRH in Adult Growth Hormone Testing [NA]
This clinical trial update reports on sexually dimorphic effects of growth hormone-releasing hormone (GHRH) in adult growth hormone testing …
-
FDA approval · 2010-02-02FDA Approved: GENOTROPIN — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for Genotropin (somatropin) from Pfizer Laboratories Div Pfizer Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2009-10-22Clinical Trial Update: Insulin Sensitivity and Substrate Metabolism Before and After Treatment in Patients With Growth Hormone Deficiency [NA]
A completed clinical trial investigating changes in insulin sensitivity and substrate metabolism in growth hormone deficiency patients befor…
-
CLINICAL_TRIALS trial_result · 2009-10-12Clinical Trial Update: Safety, Tolerability and PK/PD Study in Young Adult Patients With Childhood Onset Growth Hormone Deficiency (GHD). [Phase 2]
A completed Phase 2 study assessed the safety, tolerability, and PK/PD of Ambrx's compound in young adults with childhood-onset growth hormo…
-
CLINICAL_TRIALS trial_result · 2009-09-02Clinical Trial Update: Cardiac Function and Morphology Evaluated by Magnetic Resonance Imaging in Growth Hormone Deficiency and Acromegaly
A completed clinical trial evaluating cardiac structure and function by MRI in individuals with growth hormone deficiency and acromegaly.
-
CLINICAL_TRIALS trial_result · 2009-06-30Clinical Trial Update: Growth Hormone and Glucose Metabolism [Phase 4]
Phase 4 clinical trial update from Charité University on growth hormone and glucose metabolism in Growth Hormone Deficiency; the study statu…
-
CLINICAL_TRIALS trial_result · 2009-06-08Clinical Trial Update: Efficacy and Safety of a High Dosage Compared to the Label Dosage of Somatropin in Early Pubertal Stage Children With Growth Hormone Deficiency [Phase 3]
Phase 3 trial comparing a higher dose of Somatropin to the label dose in early-pubertal children with growth hormone deficiency; results pos…
-
CLINICAL_TRIALS trial_result · 2009-05-07Clinical Trial Update: Study of Weekly ALTU-238 Compared With Daily Nutropin AQ in Prepubertal Children With Growth Hormone Deficiency [Phase 2]
Phase 2 trial comparing weekly ALTU-238 to daily Nutropin AQ in prepubertal children with growth hormone deficiency, sponsored by Altus Phar…
-
CLINICAL_TRIALS trial_result · 2009-02-12Clinical Trial Update: Practicability and Acceptability of Stylomax® in Children [Phase 3]
A completed Phase 3 clinical trial evaluating the practicability and acceptability of Stylomax in children with growth hormone deficiency.
-
CLINICAL_TRIALS trial_result · 2009-02-10Clinical Trial Update: Cardiovascular Risk in Growth Hormone Deficient Young Adult Males After Completing Growth Hormone Therapy
The clinical trial update summarizes cardiovascular risk outcomes in growth hormone deficient young adult males after completing growth horm…
-
CLINICAL_TRIALS withdrawal · 2008-10-06Clinical Trial Update: Inter-Assay Growth Hormone and IGF-I Variability
This Clinical Trials entry indicates that the inter-assay variability study for growth hormone and IGF-I in acromegaly and growth hormone de…
-
CLINICAL_TRIALS research · 2008-08-05Clinical Trial Update: Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature Secondary [Phase 3]
A Phase 3 clinical trial update reports the completed study of Genotonorm (somatropin) in children with short stature due to growth hormone …
-
CLINICAL_TRIALS trial_result · 2008-04-01Clinical Trial Update: A Study to Evaluate the Efficacy of Somatropin in Adults With Growth Hormone Deficiency Caused by Trauma and/or Head Injury [Phase 4]
Phase 4 trial evaluating somatropin for adults with growth hormone deficiency caused by trauma or head injury has been terminated.
-
CLINICAL_TRIALS trial_result · 2008-03-28Clinical Trial Update: Replacement GH Therapy After Bariatric Surgery in Patients With Very Severe Obesity [Phase 3]
This is a Phase 3 clinical trial update on replacement growth hormone therapy after bariatric surgery in patients with very severe obesity a…
-
CLINICAL_TRIALS trial_result · 2008-02-18Clinical Trial Update: Growth Hormone Administration and Its Effects on Cardiovascular Risk Factors in Growth Hormone Deficient Women [NA]
This completed clinical trial studied the effects of growth hormone administration on cardiovascular risk factors in women with growth hormo…
-
CLINICAL_TRIALS trial_result · 2008-01-25Clinical Trial Update: Sustained Release Formulation of Somatropin (rDNA Origin)for Injection [Phase 2, Phase 3]
Phase 2/3 trial update for a sustained-release somatropin formulation (rDNA origin) for injection in growth hormone deficiency. The study st…
-
FDA approval · 2008-01-03FDA Approved: NUTROPIN AQ NUSPIN 10 — Supplemental Application (Genentech, Inc.)
The FDA approved a supplemental application for NUTROPIN AQ NUSPIN 10 (somatropin) by Genentech, updating/expanding its approved labeling.
-
CLINICAL_TRIALS trial_result · 2007-12-11Clinical Trial Update: Low and Conventional Dose of Somatropin in Growth Hormone Deficient Adult Patients [Phase 3]
Phase 3 clinical trial update evaluating low and conventional doses of somatropin in adults with growth hormone deficiency; study has comple…
-
CLINICAL_TRIALS trial_result · 2007-11-06Clinical Trial Update: Extension Study on Safety of Long-Term Growth Hormone Replacement in Adult Patients With Growth Hormone Deficiency [Phase 3]
Phase 3 extension study evaluating the safety of long-term growth hormone replacement in adults with growth hormone deficiency.
-
CLINICAL_TRIALS trial_result · 2007-10-16Clinical Trial Update: Effect of 5 Years of GH Replacement on Atherosclerosis
A completed clinical trial assesses the impact of five years of growth hormone replacement on atherosclerosis in individuals with hypopituit…
-
FDA approval · 2007-09-20FDA Approved: NORDITROPIN — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for Norditropin (somatropin) from Novo Nordisk, indicating an approved update to the existing BLA.
-
CLINICAL_TRIALS trial_result · 2007-07-30Clinical Trial Update: Transition Study: Growth Hormone Therapy In Partial Growth Hormone Deficient Adolescents [Phase 3]
Pfizer-sponsored Phase 3 transition study evaluating growth hormone therapy in adolescents with partial growth hormone deficiency has comple…